Ashton Thomas Private Wealth’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.45M | Buy |
10,958
+500
| +5% | +$203K | 0.16% | 146 |
|
|
2025
Q1 | $5.21M | Buy |
10,458
+508
| +5% | +$253K | 0.2% | 126 |
|
|
2024
Q4 | $5.18M | Buy |
9,950
+1,492
| +18% | +$777K | 0.2% | 126 |
|
|
2024
Q3 | $5.23M | Buy |
8,458
+233
| +3% | +$144K | 0.28% | 93 |
|
|
2024
Q2 | $4.55M | Buy |
8,225
+167
| +2% | +$92.4K | 0.25% | 101 |
|
|
2024
Q1 | $4.68M | Buy |
8,058
+74
| +0.9% | +$43K | 0.27% | 102 |
|
|
2023
Q4 | $4.24M | Buy |
7,984
+134
| +2% | +$71.1K | 0.27% | 106 |
|
|
2023
Q3 | $3.97M | Buy |
7,850
+497
| +7% | +$252K | 0.29% | 93 |
|
|
2023
Q2 | $3.84M | Buy |
7,353
+1,376
| +23% | +$718K | 0.29% | 89 |
|
|
2023
Q1 | $3.45M | Buy |
5,977
+387
| +7% | +$223K | 0.3% | 83 |
|
|
2022
Q4 | $3.08M | Buy |
5,590
+161
| +3% | +$88.7K | 0.31% | 97 |
|
|
2022
Q3 | $2.75M | Buy |
5,429
+65
| +1% | +$33K | 0.31% | 92 |
|
|
2022
Q2 | $2.91M | Buy |
5,364
+402
| +8% | +$218K | 0.32% | 90 |
|
|
2022
Q1 | $2.93M | Buy |
4,962
+2,130
| +75% | +$1.26M | 0.26% | 111 |
|
|
2021
Q4 | $1.89M | Buy |
2,832
+1,687
| +147% | +$1.13M | 0.18% | 142 |
|
|
2021
Q3 | $654K | Buy |
+1,145
| New | +$654K | 0.09% | 228 |
|